GlassScriptPhysician profile
Vinod K Jayam
NPI 1801953757
$13,107.72
in general payments reported to CMS, 2019-2025
19 companies · $1,191 in 2025
The $1,191 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,231 · 2020: $789 · 2021: $1,253 · 2022: $1,782 · 2023: $2,027 · 2024: $1,835 · 2025: $1,191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,379 · Travel and Lodging: $674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,378.85 |
| Travel and Lodging | $674.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,070.55 | 2019-2025 | Aveir, Jot Dx, Amplatzer Amulet |
| Boston Scientific Corporation | $1,633.99 | 2019-2025 | Watchman Flx, Avvigo Guidance System, General - Atherectomy |
| Biotronik INC. | $1,584.02 | 2020-2022 | |
| Biosense Webster, INC. | $1,308.32 | 2019-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Medtronic Vascular, INC. | $1,093.08 | 2019-2020 | |
| Medtronic, INC. | $400.61 | 2022-2025 | Mycarelink, Micra, Selectsecure |
| Janssen Pharmaceuticals, INC | $260.08 | 2019-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $249.57 | 2022-2024 | Breztri |
| Impulse Dynamics (USA) INC. | $121.07 | 2021-2023 | Optimizer |
| Kestra Medical Technology Services, INC. | $97.62 | 2022-2024 | Assure Wcd |
| Gilead Sciences, INC. | $83.63 | 2019 | |
| Vital Connect, INC | $52.65 | 2025 | Vitalpatch Rtm |
| Merck Sharp & Dohme LLC | $33.88 | 2022-2023 | Verquvo, Bridion |
| Sanofi-Aventis U.S. LLC | $25.41 | 2024 | |
| Novartis Pharmaceuticals Corporation | $22.75 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $18.53 | 2020 | |
| Amgen INC. | $18.38 | 2021 | |
| Pfizer INC. | $17.99 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinod Jayam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.